Immunocore is a series c plus startup based in United Kingdom. 2 investors tracked.
Based in the United Kingdom, Immunocore is a startup founded in 2008. Brouky records 3 investors associated with the company.
Immunocore is a biotechnology company developing T-cell receptor (TCR) based immunotherapies to target and treat cancer and other serious diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.